APO Research
Talk to an analyst

APO RESEARCH · REPORT

Second Generation Sulfonylureas

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Second Generation Sulfonylureas Market Outlook and Growth Opportunities 2026

23 December 2025190 pages

Choose your research edition.

Industry ResearchSecond Generation Sulfonylureas Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Second Generation Sulfonylureas Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Second Generation Sulfonylureas Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Second Generation Sulfonylureas Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Second Generation Sulfonylureas Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Second Generation Sulfonylureas market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Second Generation Sulfonylureas is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Second Generation Sulfonylureas is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Second Generation Sulfonylureas is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Second Generation Sulfonylureas market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Second Generation Sulfonylureas market include United Laboratories, Yiling Pharmaceutical, Takeda, Sanofi, Novo Nordisk, Merck, Eli Lilly, Jiangsu Hengrui Pharmaceuticals and Pfizer, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Second Generation Sulfonylureas market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Second Generation Sulfonylureas and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Second Generation Sulfonylureas sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Second Generation Sulfonylureas market size, projected growth trends, production technologies, key applications, and end-use industries.

Second Generation Sulfonylureas Segment by Company

United Laboratories

Yiling Pharmaceutical

Takeda

Sanofi

Novo Nordisk

Merck

Eli Lilly

Jiangsu Hengrui Pharmaceuticals

Pfizer

Beijing Double-Crane Pharmaceutical

Huadong Medicine

Beijing Beilu Pharmaceutical

AstraZeneca

Boehringer Ingelheim

Second Generation Sulfonylureas Segment by Type

Glyburide

Glipizide

Gliclazide

Others

Second Generation Sulfonylureas Segment by Application

Clinic

Hospital

Pharmacy

Others

Second Generation Sulfonylureas Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Second Generation Sulfonylureas status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Second Generation Sulfonylureas market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Second Generation Sulfonylureas significant trends, drivers, influence factors in global and regions.

6. To analyze Second Generation Sulfonylureas competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Second Generation Sulfonylureas market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Second Generation Sulfonylureas and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Second Generation Sulfonylureas.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Second Generation Sulfonylureas market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Second Generation Sulfonylureas industry.

Chapter 3: Detailed analysis of Second Generation Sulfonylureas manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Second Generation Sulfonylureas in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Second Generation Sulfonylureas in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Second Generation Sulfonylureas Industry Trends Table 2. Second Generation Sulfonylureas Industry Drivers Table 3. Second Generation Sulfonylureas Industry Opportunities and Challenges Table 4. Second Generation Sulfonylureas Industry Restraints Table 5. Global Second Generation Sulfonylureas Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Second Generation Sulfonylureas Revenue Share by Company (2021-2026) Table 7. Global Second Generation Sulfonylureas Sales Volume by Company (k units) & (2021-2026) Table 8. Global Second Generation Sulfonylureas Sales Volume Share by Company (2021-2026) Table 9. Global Second Generation Sulfonylureas Average Price (USD/unit) of Company (2021-2026) Table 10. Global Second Generation Sulfonylureas Company Ranking, (2024-2026) & (USD Million) Table 11. Global Second Generation Sulfonylureas Key Company Manufacturing Base & Headquarters Table 12. Global Second Generation Sulfonylureas Company, Product Type & Application Table 13. Global Second Generation Sulfonylureas Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Second Generation Sulfonylureas by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Glyburide Table 18. Significant Companies of Glipizide Table 19. Significant Companies of Gliclazide Table 20. Significant Companies of Others Table 21. Global Second Generation Sulfonylureas Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 22. Global Second Generation Sulfonylureas Sales Volume by Type (2021-2026) & (k units) Table 23. Global Second Generation Sulfonylureas Sales Volume by Type (2027-2032) & (k units) Table 24. Global Second Generation Sulfonylureas Sales Volume Share by Type (2021-2026) Table 25. Global Second Generation Sulfonylureas Sales Volume Share by Type (2027-2032) Table 26. Global Second Generation Sulfonylureas Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Second Generation Sulfonylureas Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Second Generation Sulfonylureas Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Second Generation Sulfonylureas Sales Value Share by Type (2021-2026) Table 30. Global Second Generation Sulfonylureas Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Clinic Table 32. Significant Companies of Hospital Table 33. Significant Companies of Pharmacy Table 34. Significant Companies of Others Table 35. Global Second Generation Sulfonylureas Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 36. Global Second Generation Sulfonylureas Sales Volume by Application (2021-2026) & (k units) Table 37. Global Second Generation Sulfonylureas Sales Volume by Application (2027-2032) & (k units) Table 38. Global Second Generation Sulfonylureas Sales Volume Share by Application (2021-2026) Table 39. Global Second Generation Sulfonylureas Sales Volume Share by Application (2027-2032) Table 40. Global Second Generation Sulfonylureas Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Second Generation Sulfonylureas Sales Value by Application (2021-2026) & (US$ Million) Table 42. Global Second Generation Sulfonylureas Sales Value by Application (2027-2032) & (US$ Million) Table 43. Global Second Generation Sulfonylureas Sales Value Share by Application (2021-2026) Table 44. Global Second Generation Sulfonylureas Sales Value Share by Application (2027-2032) Table 45. Global Second Generation Sulfonylureas Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 46. Global Second Generation Sulfonylureas Sales by Region (2021-2026) & (k units) Table 47. Global Second Generation Sulfonylureas Sales Market Share by Region (2021-2026) Table 48. Global Second Generation Sulfonylureas Sales by Region (2027-2032) & (k units) Table 49. Global Second Generation Sulfonylureas Sales Market Share by Region (2027-2032) Table 50. Global Second Generation Sulfonylureas Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Second Generation Sulfonylureas Sales Value by Region (2021-2026) & (US$ Million) Table 52. Global Second Generation Sulfonylureas Sales Value Share by Region (2021-2026) Table 53. Global Second Generation Sulfonylureas Sales Value by Region (2027-2032) & (US$ Million) Table 54. Global Second Generation Sulfonylureas Sales Value Share by Region (2027-2032) Table 55. Global Second Generation Sulfonylureas Market Average Price (USD/unit) by Region (2021-2026) Table 56. Global Second Generation Sulfonylureas Market Average Price (USD/unit) by Region (2027-2032) Table 57. Global Second Generation Sulfonylureas Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 58. Global Second Generation Sulfonylureas Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Second Generation Sulfonylureas Sales by Country (2021-2026) & (k units) Table 60. Global Second Generation Sulfonylureas Sales Market Share by Country (2021-2026) Table 61. Global Second Generation Sulfonylureas Sales by Country (2027-2032) & (k units) Table 62. Global Second Generation Sulfonylureas Sales Market Share by Country (2027-2032) Table 63. Global Second Generation Sulfonylureas Sales Value by Country (2021-2026) & (US$ Million) Table 64. Global Second Generation Sulfonylureas Sales Value Market Share by Country (2021-2026) Table 65. Global Second Generation Sulfonylureas Sales Value by Country (2027-2032) & (US$ Million) Table 66. Global Second Generation Sulfonylureas Sales Value Market Share by Country (2027-2032) Table 67. United Laboratories Company Information Table 68. United Laboratories Business Overview Table 69. United Laboratories Second Generation Sulfonylureas Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 70. United Laboratories Second Generation Sulfonylureas Product Portfolio Table 71. United Laboratories Recent Development Table 72. Yiling Pharmaceutical Company Information Table 73. Yiling Pharmaceutical Business Overview Table 74. Yiling Pharmaceutical Second Generation Sulfonylureas Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 75. Yiling Pharmaceutical Second Generation Sulfonylureas Product Portfolio Table 76. Yiling Pharmaceutical Recent Development Table 77. Takeda Company Information Table 78. Takeda Business Overview Table 79. Takeda Second Generation Sulfonylureas Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 80. Takeda Second Generation Sulfonylureas Product Portfolio Table 81. Takeda Recent Development Table 82. Sanofi Company Information Table 83. Sanofi Business Overview Table 84. Sanofi Second Generation Sulfonylureas Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 85. Sanofi Second Generation Sulfonylureas Product Portfolio Table 86. Sanofi Recent Development Table 87. Novo Nordisk Company Information Table 88. Novo Nordisk Business Overview Table 89. Novo Nordisk Second Generation Sulfonylureas Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 90. Novo Nordisk Second Generation Sulfonylureas Product Portfolio Table 91. Novo Nordisk Recent Development Table 92. Merck Company Information Table 93. Merck Business Overview Table 94. Merck Second Generation Sulfonylureas Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. Merck Second Generation Sulfonylureas Product Portfolio Table 96. Merck Recent Development Table 97. Eli Lilly Company Information Table 98. Eli Lilly Business Overview Table 99. Eli Lilly Second Generation Sulfonylureas Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. Eli Lilly Second Generation Sulfonylureas Product Portfolio Table 101. Eli Lilly Recent Development Table 102. Jiangsu Hengrui Pharmaceuticals Company Information Table 103. Jiangsu Hengrui Pharmaceuticals Business Overview Table 104. Jiangsu Hengrui Pharmaceuticals Second Generation Sulfonylureas Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. Jiangsu Hengrui Pharmaceuticals Second Generation Sulfonylureas Product Portfolio Table 106. Jiangsu Hengrui Pharmaceuticals Recent Development Table 107. Pfizer Company Information Table 108. Pfizer Business Overview Table 109. Pfizer Second Generation Sulfonylureas Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 110. Pfizer Second Generation Sulfonylureas Product Portfolio Table 111. Pfizer Recent Development Table 112. Beijing Double-Crane Pharmaceutical Company Information Table 113. Beijing Double-Crane Pharmaceutical Business Overview Table 114. Beijing Double-Crane Pharmaceutical Second Generation Sulfonylureas Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 115. Beijing Double-Crane Pharmaceutical Second Generation Sulfonylureas Product Portfolio Table 116. Beijing Double-Crane Pharmaceutical Recent Development Table 117. Huadong Medicine Company Information Table 118. Huadong Medicine Business Overview Table 119. Huadong Medicine Second Generation Sulfonylureas Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 120. Huadong Medicine Second Generation Sulfonylureas Product Portfolio Table 121. Huadong Medicine Recent Development Table 122. Beijing Beilu Pharmaceutical Company Information Table 123. Beijing Beilu Pharmaceutical Business Overview Table 124. Beijing Beilu Pharmaceutical Second Generation Sulfonylureas Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 125. Beijing Beilu Pharmaceutical Second Generation Sulfonylureas Product Portfolio Table 126. Beijing Beilu Pharmaceutical Recent Development Table 127. AstraZeneca Company Information Table 128. AstraZeneca Business Overview Table 129. AstraZeneca Second Generation Sulfonylureas Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 130. AstraZeneca Second Generation Sulfonylureas Product Portfolio Table 131. AstraZeneca Recent Development Table 132. Boehringer Ingelheim Company Information Table 133. Boehringer Ingelheim Business Overview Table 134. Boehringer Ingelheim Second Generation Sulfonylureas Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 135. Boehringer Ingelheim Second Generation Sulfonylureas Product Portfolio Table 136. Boehringer Ingelheim Recent Development Table 137. Key Raw Materials Table 138. Raw Materials Key Suppliers Table 139. Second Generation Sulfonylureas Distributors List Table 140. Second Generation Sulfonylureas Customers List Table 141. Research Programs/Design for This Report Table 142. Authors List of This Report Table 143. Secondary Sources Table 144. Primary Sources List of Figures Figure 1. Second Generation Sulfonylureas Product Image Figure 2. Global Second Generation Sulfonylureas Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Second Generation Sulfonylureas Sales Value (2021-2032) & (US$ Million) Figure 4. Global Second Generation Sulfonylureas Sales (2021-2032) & (k units) Figure 5. Global Second Generation Sulfonylureas Sales Average Price (USD/unit) & (2021-2032) Figure 6. Global Second Generation Sulfonylureas Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Glyburide Image Figure 10. Glipizide Image Figure 11. Gliclazide Image Figure 12. Others Image Figure 13. Global Second Generation Sulfonylureas Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Second Generation Sulfonylureas Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Second Generation Sulfonylureas Sales Volume Share by Type (2021-2032) Figure 16. Global Second Generation Sulfonylureas Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Second Generation Sulfonylureas Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Second Generation Sulfonylureas Sales Value Share by Type (2021-2032) Figure 19. Clinic Image Figure 20. Hospital Image Figure 21. Pharmacy Image Figure 22. Others Image Figure 23. Global Second Generation Sulfonylureas Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 24. Global Second Generation Sulfonylureas Sales Volume Share 2021 VS 2025 VS 2032 Figure 25. Global Second Generation Sulfonylureas Sales Volume Share by Application (2021-2032) Figure 26. Global Second Generation Sulfonylureas Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Second Generation Sulfonylureas Sales Value Share 2021 VS 2025 VS 2032 Figure 28. Global Second Generation Sulfonylureas Sales Value Share by Application (2021-2032) Figure 29. Global Second Generation Sulfonylureas Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 30. Global Second Generation Sulfonylureas Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 31. Global Second Generation Sulfonylureas Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 32. Global Second Generation Sulfonylureas Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 33. North America Second Generation Sulfonylureas Sales Value (2021-2032) & (US$ Million) Figure 34. North America Second Generation Sulfonylureas Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Europe Second Generation Sulfonylureas Sales Value (2021-2032) & (US$ Million) Figure 36. Europe Second Generation Sulfonylureas Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Asia-Pacific Second Generation Sulfonylureas Sales Value (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Second Generation Sulfonylureas Sales Value Share by Country (%), 2025 VS 2032 Figure 39. South America Second Generation Sulfonylureas Sales Value (2021-2032) & (US$ Million) Figure 40. South America Second Generation Sulfonylureas Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Middle East & Africa Second Generation Sulfonylureas Sales Value (2021-2032) & (US$ Million) Figure 42. Middle East & Africa Second Generation Sulfonylureas Sales Value Share by Country (%), 2025 VS 2032 Figure 43. USA Second Generation Sulfonylureas Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. USA Second Generation Sulfonylureas Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. USA Second Generation Sulfonylureas Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Canada Second Generation Sulfonylureas Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Canada Second Generation Sulfonylureas Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Canada Second Generation Sulfonylureas Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Mexico Second Generation Sulfonylureas Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Mexico Second Generation Sulfonylureas Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Mexico Second Generation Sulfonylureas Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Germany Second Generation Sulfonylureas Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Germany Second Generation Sulfonylureas Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Germany Second Generation Sulfonylureas Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. France Second Generation Sulfonylureas Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. France Second Generation Sulfonylureas Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. France Second Generation Sulfonylureas Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. U.K. Second Generation Sulfonylureas Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. U.K. Second Generation Sulfonylureas Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. U.K. Second Generation Sulfonylureas Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Italy Second Generation Sulfonylureas Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Italy Second Generation Sulfonylureas Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Italy Second Generation Sulfonylureas Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Spain Second Generation Sulfonylureas Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Spain Second Generation Sulfonylureas Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Spain Second Generation Sulfonylureas Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Russia Second Generation Sulfonylureas Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Russia Second Generation Sulfonylureas Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Russia Second Generation Sulfonylureas Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Netherlands Second Generation Sulfonylureas Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Netherlands Second Generation Sulfonylureas Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Netherlands Second Generation Sulfonylureas Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Nordic Countries Second Generation Sulfonylureas Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Nordic Countries Second Generation Sulfonylureas Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Nordic Countries Second Generation Sulfonylureas Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. China Second Generation Sulfonylureas Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. China Second Generation Sulfonylureas Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. China Second Generation Sulfonylureas Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Japan Second Generation Sulfonylureas Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Japan Second Generation Sulfonylureas Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Japan Second Generation Sulfonylureas Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. South Korea Second Generation Sulfonylureas Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. South Korea Second Generation Sulfonylureas Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. South Korea Second Generation Sulfonylureas Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. India Second Generation Sulfonylureas Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. India Second Generation Sulfonylureas Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. India Second Generation Sulfonylureas Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Australia Second Generation Sulfonylureas Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Australia Second Generation Sulfonylureas Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Australia Second Generation Sulfonylureas Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Southeast Asia Second Generation Sulfonylureas Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Southeast Asia Second Generation Sulfonylureas Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Southeast Asia Second Generation Sulfonylureas Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Brazil Second Generation Sulfonylureas Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Brazil Second Generation Sulfonylureas Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Brazil Second Generation Sulfonylureas Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Argentina Second Generation Sulfonylureas Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Argentina Second Generation Sulfonylureas Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Argentina Second Generation Sulfonylureas Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Chile Second Generation Sulfonylureas Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Chile Second Generation Sulfonylureas Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Chile Second Generation Sulfonylureas Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Colombia Second Generation Sulfonylureas Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Colombia Second Generation Sulfonylureas Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Colombia Second Generation Sulfonylureas Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Peru Second Generation Sulfonylureas Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Peru Second Generation Sulfonylureas Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Peru Second Generation Sulfonylureas Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Second Generation Sulfonylureas Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Saudi Arabia Second Generation Sulfonylureas Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Second Generation Sulfonylureas Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Israel Second Generation Sulfonylureas Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Israel Arabia Second Generation Sulfonylureas Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Israel Arabia Second Generation Sulfonylureas Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. UAE Second Generation Sulfonylureas Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. UAE Second Generation Sulfonylureas Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. UAE Second Generation Sulfonylureas Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Turkey Second Generation Sulfonylureas Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Turkey Second Generation Sulfonylureas Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Turkey Second Generation Sulfonylureas Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Iran Second Generation Sulfonylureas Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Iran Second Generation Sulfonylureas Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Iran Second Generation Sulfonylureas Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Egypt Second Generation Sulfonylureas Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Egypt Second Generation Sulfonylureas Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Egypt Second Generation Sulfonylureas Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Second Generation Sulfonylureas Value Chain Figure 128. Manufacturing Cost Structure Figure 129. Second Generation Sulfonylureas Sales Mode & Process Figure 130. Direct Comparison with Distribution Share Figure 131. Distributors Profiles Figure 132. Years Considered Figure 133. Research Process Figure 134. Key Executives Interviewed

Scope & coverage.

Types
  • Glyburide
  • Glipizide
  • Gliclazide
  • Others
Applications
  • Clinic
  • Hospital
  • Pharmacy
  • Others
Companies covered
  • United Laboratories
  • Yiling Pharmaceutical
  • Takeda
  • Sanofi
  • Novo Nordisk
  • Merck
  • Eli Lilly
  • Jiangsu Hengrui Pharmaceuticals
  • Pfizer
  • Beijing Double-Crane Pharmaceutical
  • Huadong Medicine
  • Beijing Beilu Pharmaceutical
  • AstraZeneca
  • Boehringer Ingelheim

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Second Generation Sulfonylureas Sales Value (2021-2032)
  4. 1.2.2 Global Second Generation Sulfonylureas Sales Volume (2021-2032)
  5. 1.2.3 Global Second Generation Sulfonylureas Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Second Generation Sulfonylureas Market Dynamics
  1. 2.1 Second Generation Sulfonylureas Industry Trends
  2. 2.2 Second Generation Sulfonylureas Industry Drivers
  3. 2.3 Second Generation Sulfonylureas Industry Opportunities and Challenges
  4. 2.4 Second Generation Sulfonylureas Industry Restraints
3 Second Generation Sulfonylureas Market by Company
  1. 3.1 Global Second Generation Sulfonylureas Company Revenue Ranking in 2025
  2. 3.2 Global Second Generation Sulfonylureas Revenue by Company (2021-2026)
  3. 3.3 Global Second Generation Sulfonylureas Sales Volume by Company (2021-2026)
  4. 3.4 Global Second Generation Sulfonylureas Average Price by Company (2021-2026)
  5. 3.5 Global Second Generation Sulfonylureas Company Ranking (2024-2026)
  6. 3.6 Global Second Generation Sulfonylureas Company Manufacturing Base and Headquarters
  7. 3.7 Global Second Generation Sulfonylureas Company Product Type and Application
  8. 3.8 Global Second Generation Sulfonylureas Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Second Generation Sulfonylureas Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Second Generation Sulfonylureas Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Second Generation Sulfonylureas Market by Type
  1. 4.1 Second Generation Sulfonylureas Type Introduction
  2. 4.1.1 Glyburide
  3. 4.1.2 Glipizide
  4. 4.1.3 Gliclazide
  5. 4.1.4 Others
  6. 4.2 Global Second Generation Sulfonylureas Sales Volume by Type
  7. 4.2.1 Global Second Generation Sulfonylureas Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Second Generation Sulfonylureas Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Second Generation Sulfonylureas Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Second Generation Sulfonylureas Sales Value by Type
  11. 4.3.1 Global Second Generation Sulfonylureas Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Second Generation Sulfonylureas Sales Value by Type (2021-2032)
  13. 4.3.3 Global Second Generation Sulfonylureas Sales Value Share by Type (2021-2032)
5 Second Generation Sulfonylureas Market by Application
  1. 5.1 Second Generation Sulfonylureas Application Introduction
  2. 5.1.1 Clinic
  3. 5.1.2 Hospital
  4. 5.1.3 Pharmacy
  5. 5.1.4 Others
  6. 5.2 Global Second Generation Sulfonylureas Sales Volume by Application
  7. 5.2.1 Global Second Generation Sulfonylureas Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Second Generation Sulfonylureas Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Second Generation Sulfonylureas Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Second Generation Sulfonylureas Sales Value by Application
  11. 5.3.1 Global Second Generation Sulfonylureas Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Second Generation Sulfonylureas Sales Value by Application (2021-2032)
  13. 5.3.3 Global Second Generation Sulfonylureas Sales Value Share by Application (2021-2032)
6 Second Generation Sulfonylureas Regional Sales and Value Analysis
  1. 6.1 Global Second Generation Sulfonylureas Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Second Generation Sulfonylureas Sales by Region (2021-2032)
  3. 6.2.1 Global Second Generation Sulfonylureas Sales by Region: 2021-2026
  4. 6.2.2 Global Second Generation Sulfonylureas Sales by Region (2027-2032)
  5. 6.3 Global Second Generation Sulfonylureas Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Second Generation Sulfonylureas Sales Value by Region (2021-2032)
  7. 6.4.1 Global Second Generation Sulfonylureas Sales Value by Region: 2021-2026
  8. 6.4.2 Global Second Generation Sulfonylureas Sales Value by Region (2027-2032)
  9. 6.5 Global Second Generation Sulfonylureas Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Second Generation Sulfonylureas Sales Value (2021-2032)
  12. 6.6.2 North America Second Generation Sulfonylureas Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Second Generation Sulfonylureas Sales Value (2021-2032)
  15. 6.7.2 Europe Second Generation Sulfonylureas Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Second Generation Sulfonylureas Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Second Generation Sulfonylureas Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Second Generation Sulfonylureas Sales Value (2021-2032)
  21. 6.9.2 South America Second Generation Sulfonylureas Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Second Generation Sulfonylureas Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Second Generation Sulfonylureas Sales Value Share by Country, 2025 VS 2032
7 Second Generation Sulfonylureas Country-level Sales and Value Analysis
  1. 7.1 Global Second Generation Sulfonylureas Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Second Generation Sulfonylureas Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Second Generation Sulfonylureas Sales by Country (2021-2032)
  4. 7.3.1 Global Second Generation Sulfonylureas Sales by Country (2021-2026)
  5. 7.3.2 Global Second Generation Sulfonylureas Sales by Country (2027-2032)
  6. 7.4 Global Second Generation Sulfonylureas Sales Value by Country (2021-2032)
  7. 7.4.1 Global Second Generation Sulfonylureas Sales Value by Country (2021-2026)
  8. 7.4.2 Global Second Generation Sulfonylureas Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Second Generation Sulfonylureas Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Second Generation Sulfonylureas Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Second Generation Sulfonylureas Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Second Generation Sulfonylureas Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Second Generation Sulfonylureas Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Second Generation Sulfonylureas Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Second Generation Sulfonylureas Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Second Generation Sulfonylureas Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Second Generation Sulfonylureas Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Second Generation Sulfonylureas Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Second Generation Sulfonylureas Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Second Generation Sulfonylureas Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Second Generation Sulfonylureas Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Second Generation Sulfonylureas Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Second Generation Sulfonylureas Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Second Generation Sulfonylureas Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Second Generation Sulfonylureas Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Second Generation Sulfonylureas Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Second Generation Sulfonylureas Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Second Generation Sulfonylureas Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Second Generation Sulfonylureas Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Second Generation Sulfonylureas Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Second Generation Sulfonylureas Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Second Generation Sulfonylureas Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Second Generation Sulfonylureas Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Second Generation Sulfonylureas Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Second Generation Sulfonylureas Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Second Generation Sulfonylureas Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Second Generation Sulfonylureas Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Second Generation Sulfonylureas Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Second Generation Sulfonylureas Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Second Generation Sulfonylureas Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Second Generation Sulfonylureas Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Second Generation Sulfonylureas Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Second Generation Sulfonylureas Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Second Generation Sulfonylureas Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Second Generation Sulfonylureas Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Second Generation Sulfonylureas Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Second Generation Sulfonylureas Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Second Generation Sulfonylureas Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Second Generation Sulfonylureas Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Second Generation Sulfonylureas Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Second Generation Sulfonylureas Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Second Generation Sulfonylureas Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Second Generation Sulfonylureas Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Second Generation Sulfonylureas Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Second Generation Sulfonylureas Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Second Generation Sulfonylureas Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Second Generation Sulfonylureas Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Second Generation Sulfonylureas Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Second Generation Sulfonylureas Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Second Generation Sulfonylureas Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Second Generation Sulfonylureas Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Second Generation Sulfonylureas Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Second Generation Sulfonylureas Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Second Generation Sulfonylureas Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Second Generation Sulfonylureas Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Second Generation Sulfonylureas Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Second Generation Sulfonylureas Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Second Generation Sulfonylureas Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Second Generation Sulfonylureas Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Second Generation Sulfonylureas Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Second Generation Sulfonylureas Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Second Generation Sulfonylureas Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Second Generation Sulfonylureas Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Second Generation Sulfonylureas Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Second Generation Sulfonylureas Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Second Generation Sulfonylureas Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Second Generation Sulfonylureas Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Second Generation Sulfonylureas Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Second Generation Sulfonylureas Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Second Generation Sulfonylureas Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Second Generation Sulfonylureas Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Second Generation Sulfonylureas Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Second Generation Sulfonylureas Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Second Generation Sulfonylureas Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Second Generation Sulfonylureas Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Second Generation Sulfonylureas Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Second Generation Sulfonylureas Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Second Generation Sulfonylureas Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Second Generation Sulfonylureas Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Second Generation Sulfonylureas Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Second Generation Sulfonylureas Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Second Generation Sulfonylureas Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 United Laboratories
  2. 8.1.1 United Laboratories Company Information
  3. 8.1.2 United Laboratories Business Overview
  4. 8.1.3 United Laboratories Second Generation Sulfonylureas Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 United Laboratories Second Generation Sulfonylureas Product Portfolio
  6. 8.1.5 United Laboratories Recent Developments
  7. 8.2 Yiling Pharmaceutical
  8. 8.2.1 Yiling Pharmaceutical Company Information
  9. 8.2.2 Yiling Pharmaceutical Business Overview
  10. 8.2.3 Yiling Pharmaceutical Second Generation Sulfonylureas Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Yiling Pharmaceutical Second Generation Sulfonylureas Product Portfolio
  12. 8.2.5 Yiling Pharmaceutical Recent Developments
  13. 8.3 Takeda
  14. 8.3.1 Takeda Company Information
  15. 8.3.2 Takeda Business Overview
  16. 8.3.3 Takeda Second Generation Sulfonylureas Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Takeda Second Generation Sulfonylureas Product Portfolio
  18. 8.3.5 Takeda Recent Developments
  19. 8.4 Sanofi
  20. 8.4.1 Sanofi Company Information
  21. 8.4.2 Sanofi Business Overview
  22. 8.4.3 Sanofi Second Generation Sulfonylureas Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Sanofi Second Generation Sulfonylureas Product Portfolio
  24. 8.4.5 Sanofi Recent Developments
  25. 8.5 Novo Nordisk
  26. 8.5.1 Novo Nordisk Company Information
  27. 8.5.2 Novo Nordisk Business Overview
  28. 8.5.3 Novo Nordisk Second Generation Sulfonylureas Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Novo Nordisk Second Generation Sulfonylureas Product Portfolio
  30. 8.5.5 Novo Nordisk Recent Developments
  31. 8.6 Merck
  32. 8.6.1 Merck Company Information
  33. 8.6.2 Merck Business Overview
  34. 8.6.3 Merck Second Generation Sulfonylureas Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Merck Second Generation Sulfonylureas Product Portfolio
  36. 8.6.5 Merck Recent Developments
  37. 8.7 Eli Lilly
  38. 8.7.1 Eli Lilly Company Information
  39. 8.7.2 Eli Lilly Business Overview
  40. 8.7.3 Eli Lilly Second Generation Sulfonylureas Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Eli Lilly Second Generation Sulfonylureas Product Portfolio
  42. 8.7.5 Eli Lilly Recent Developments
  43. 8.8 Jiangsu Hengrui Pharmaceuticals
  44. 8.8.1 Jiangsu Hengrui Pharmaceuticals Company Information
  45. 8.8.2 Jiangsu Hengrui Pharmaceuticals Business Overview
  46. 8.8.3 Jiangsu Hengrui Pharmaceuticals Second Generation Sulfonylureas Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Jiangsu Hengrui Pharmaceuticals Second Generation Sulfonylureas Product Portfolio
  48. 8.8.5 Jiangsu Hengrui Pharmaceuticals Recent Developments
  49. 8.9 Pfizer
  50. 8.9.1 Pfizer Company Information
  51. 8.9.2 Pfizer Business Overview
  52. 8.9.3 Pfizer Second Generation Sulfonylureas Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Pfizer Second Generation Sulfonylureas Product Portfolio
  54. 8.9.5 Pfizer Recent Developments
  55. 8.10 Beijing Double-Crane Pharmaceutical
  56. 8.10.1 Beijing Double-Crane Pharmaceutical Company Information
  57. 8.10.2 Beijing Double-Crane Pharmaceutical Business Overview
  58. 8.10.3 Beijing Double-Crane Pharmaceutical Second Generation Sulfonylureas Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Beijing Double-Crane Pharmaceutical Second Generation Sulfonylureas Product Portfolio
  60. 8.10.5 Beijing Double-Crane Pharmaceutical Recent Developments
  61. 8.11 Huadong Medicine
  62. 8.11.1 Huadong Medicine Company Information
  63. 8.11.2 Huadong Medicine Business Overview
  64. 8.11.3 Huadong Medicine Second Generation Sulfonylureas Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Huadong Medicine Second Generation Sulfonylureas Product Portfolio
  66. 8.11.5 Huadong Medicine Recent Developments
  67. 8.12 Beijing Beilu Pharmaceutical
  68. 8.12.1 Beijing Beilu Pharmaceutical Company Information
  69. 8.12.2 Beijing Beilu Pharmaceutical Business Overview
  70. 8.12.3 Beijing Beilu Pharmaceutical Second Generation Sulfonylureas Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Beijing Beilu Pharmaceutical Second Generation Sulfonylureas Product Portfolio
  72. 8.12.5 Beijing Beilu Pharmaceutical Recent Developments
  73. 8.13 AstraZeneca
  74. 8.13.1 AstraZeneca Company Information
  75. 8.13.2 AstraZeneca Business Overview
  76. 8.13.3 AstraZeneca Second Generation Sulfonylureas Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 AstraZeneca Second Generation Sulfonylureas Product Portfolio
  78. 8.13.5 AstraZeneca Recent Developments
  79. 8.14 Boehringer Ingelheim
  80. 8.14.1 Boehringer Ingelheim Company Information
  81. 8.14.2 Boehringer Ingelheim Business Overview
  82. 8.14.3 Boehringer Ingelheim Second Generation Sulfonylureas Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Boehringer Ingelheim Second Generation Sulfonylureas Product Portfolio
  84. 8.14.5 Boehringer Ingelheim Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Second Generation Sulfonylureas Value Chain Analysis
  2. 9.1.1 Second Generation Sulfonylureas Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Second Generation Sulfonylureas Sales Mode & Process
  6. 9.2 Second Generation Sulfonylureas Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Second Generation Sulfonylureas Distributors
  9. 9.2.3 Second Generation Sulfonylureas Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst